Submitted:
17 September 2024
Posted:
18 September 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Retrospective Cohortstudy
2.2. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Rao, S.N.; Manissero, D.; Steele, V.R.; Pareja, J. A systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther 2020, 9, 573–586. [Google Scholar] [CrossRef]
- Aranha, C.; Patel, V.; Bhor, V.; Gogoi, D. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients. J Med Virol 2021, 93, 6794–6797. [Google Scholar] [CrossRef] [PubMed]
- Hwang, J.; Yuen, A.; Rhoades, J.; Barnes, D.; Zakowski, P.; Megna, D.J.; Catarino, P.; Zaffiri, L.; Rampolla, R. Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors. J Heart Lung Transplant 2022, 28, S1053–2498. [Google Scholar] [CrossRef] [PubMed]
- Yang, D.; Hansel, D.E.; Curlin, M.E.; Townes, J.M.; Messer, W.B.; Fan, G.; Qin, X. Bimodal distribution pattern associated with the PCR cycle threshold (Ct) and implications in COVID-19 infections. Sci Rep 2022, 12, 14544. [Google Scholar] [CrossRef]
- Kimball, A.; Hatfield, K.M.; Arons, M.; James, A.; Taylor, J.; Spicer, K.; Bardossy, A.C.; Oakley, L.P.; Tanwar, S.; Chisty, Z.; et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep 2020, 69, 377–381. [Google Scholar] [CrossRef] [PubMed]
- Arons, M.M.; Hatfield, K.M.; Reddy, S.C.; Kimball, A.; James, A.; Jacobs, J.R.; Taylor, J.; Spicer, K.; Bardossy, A.C.; Oakley, L.P.; et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med 2020, 382, 2081–2090. [Google Scholar] [CrossRef] [PubMed]
- Paap, K.C.; van Loon, A.M.; Koene, F.M.; van Buul, L.W.; Jurriaans, S.; Smalbrugge, M.; de Jong, M.D.; Hertogh, C.M.P.M. Clinical evaluation of single-swab sampling for rapid COVID-19 detection in outbreak settings in Dutch nursing homes. Eur Geriatr Med. 2022, 13, 711–718. [Google Scholar] [CrossRef]
- Chung, H.Y.; Jian, M.J.; Chang, C.K.; Lin, J.C.; Yeh, K.M.; Chen, C.W.; Hsieh, S.S.; Hung, K.S.; Tang, S.H.; Perng, C.L; et al. Emergency SARS-CoV-2 variants of concern: Novel multiplex real-time RT-PCR assay for rapid detection and surveillance. Microbiol Spectr 2022, 10, e0251321. [Google Scholar] [CrossRef] [PubMed]
- Tso, C.F.; Garikipati, A.; Green-Saxena, A.; Mao, Q.; Das, R. Correlation of population SARS-CoV-2 cycle threshold values to local disease dynamics: Exploratory observational study. JMIR Public Health Surveill 2021, 7, e28265. [Google Scholar] [CrossRef]
- Harrison, R.E.; Hamada, A.; Haswell, N.; Groves, A.; Vihta, K.D.; Cella, K.; Garner, S.; Walker, A.S.; Seale, A.C. Cycle threshold values as indication of increasing SARS-CoV-2 new variants, England, 2020-2022. Emerg Infect Dis. 2023, 29, 2024–2031. [Google Scholar] [CrossRef] [PubMed]
- Konetzka, R.T.; White, E.M.; Pralea, A.; Grabowski, D.C.; Mor, V. A systematic review of long-term care facility characteristics associated with COVID-19 outcomes. J Am Geriatr Soc 2021, 69, 2766–2777. [Google Scholar] [CrossRef] [PubMed]
- Arnedo-Pena, A.; Romeu-Garcia, M.A.; Gascó-Laborda, J.C.; Meseguer-Ferrer, N.; Safont-Adsuara, L.; Prades-Vila, L.; Flores-Medina, M.; Rusen, V.; Tirado-Balaguer, M.D.; Sabater-Vidal, S.; et al. Incidence, mortality, and risk factors of COVID-19 in nursing homes. Epidemiologia (Basel) 2022, 3, 179–190. [Google Scholar] [CrossRef] [PubMed]
- Singanayagam, A.; Patel, M.; Charlett, A.; Lopez Bernal, J.; Saliba, V.; Ellis, J.; Ladhani, S.; Zambon, M.; Gopal, R. ; Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 2020, 25, 2001483. [Google Scholar] [CrossRef]
- Girón Pérez, D.A.; Fonseca-Agüero, A.; Toledo-Ibarra, G.A.; Gomez-Valdivia, J.J.; Díaz-Resendiz, K.J.G.; Benitez-Trinidad, A.B.; Razura-Carmona, F.F.; Navidad-Murrieta, M.S.; Covantes-Rosales, C.E.; Giron-Pérez, M.I. Post-COVID-19 syndrome in outpatients and its association with viral load. Int J Environ Res Public Health 2022, 19, 15145. [Google Scholar] [CrossRef] [PubMed]
- Eyre, D.W.; Taylor, D.; Purver, M.; Chapman, D.; Fowler, T.; Pouwels, K.B.; Walker, A.S.; Peto, T.E.A. Effect of Covid-19 vaccination on transmission of Alpha and Delta variants. N Engl J Med 2022, 386, 744–756. [Google Scholar] [CrossRef] [PubMed]
- McEllistrem, M.C.; Clancy, C.J.; Buehrle, D.J.; Lucas, A.; Decker, B.K. Single dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) vaccine is associated With lower nasopharyngeal viral load among nursing home residents with asymptomatic coronavirus disease 2019 (COVID-19). Clin Infect Dis 2021, 73, e1365–e1367. [Google Scholar] [CrossRef]
- Kapoor, M.; Kalita, D.; Panda, P.K. Cycle threshold values versus reverse transcription-polymerase chain reaction positivity in COVID-19 de-isolation. Indian J Med Microbiol 2021, 39, 133–135. [Google Scholar] [CrossRef] [PubMed]
- Wünsch, K.; Anastasiou, O.E.; Alt, M.; Brochhagen, L.; Cherneha, M.; Thümmler, L.; van Baal, L.; Madel, R.J.; Lindemann, M.; Taube, C.; et al. COVID-19 in elderly, immunocompromised or diabetic patients-From immune monitoring to clinical management in the hospital. Viruses 2022, 14, 746. [Google Scholar] [CrossRef]
- McKay, S.L.; Tobolowsky, F.A.; Moritz, E.D.; Hatfield, K.M.; Bhatnagar, A.; LaVoie, S.P.; Jackson, D.A.; Lecy, K.D.; Bryant-Genevier, J.; Campbell, D.; et al. Performance evaluation of serial SARS-CoV-2 rapid antigen testing during a nursing home outbreak. Ann Intern Med 2021, 174, 945–951. [Google Scholar] [CrossRef] [PubMed]
- Leitão, I.C.; Calil, P.T.; Galliez, R.M.; Moreira, F.R.R.; Mariani, D.; Castiñeiras, A.C.P.; da Silva, G.P.D.; Maia, R.A.; Corrêa, I.A.; Monteiro, F.L.L.; et al. Prolonged SARS-CoV-2 positivity in immunocompetent patients: virus isolation, genomic integrity, and transmission risk. Microbiol Spectr 2021, 9, e0085521. [Google Scholar] [CrossRef]
- Shoaib, N.; Noureen, N.; Faisal, A.; Zaheer, M.; Imran, M.; Ahsan, A.; Munir, R.; Zaidi, N. Factors associated with cycle threshold values (Ct-values) of SARS-CoV2-rRT-PCR. Mol Biol Rep 2022, 49, 4101–4106. [Google Scholar] [CrossRef]
- Rhoads, D.D.; Pinsky, B.A. The truth about SARS-CoV-2 cycle threshold values is rarely pure and never simple. Clin Chem 2021, 68, 16–18. [Google Scholar] [CrossRef]
- Fan, G.; Jin, Y.; Wang, Q.; Yue, Y. Assessing the comparability of cycle threshold values derived from five external quality assessment rounds for Omicron nucleic acid testing. Virol J 2023, 20, 119. [Google Scholar] [CrossRef] [PubMed]
- Yip, C.C.; Sridhar, S.; Cheng, A.K.; Leung, K.H.; Choi, G.K.; Chen, J.H.; Poon, R.W.; Chan, K.H.; Wu, A.K.; Chan, H.S.; et al. Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection. J Clin Virol 2020, 129, 104476. [Google Scholar] [CrossRef] [PubMed]
- Ministerio de Sanidad. Estrategia de detección precoz, vigilancia y control de COVID-19. Centro de Coordinación de Alertas y Emergencias Sanitarias. Actualizado 22 de diciembre de 2021. Available online: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf (accessed on 28 June 2022).
- European Centre for Disease Prevention and Control Reinfection with SARS-CoV-2: Implementation of a Surveillance Case Definition within the EU/EEA. 2021. Available online: https://www.ecdc.europa.eu/en/publications-data/reinfection-sars-cov-2-implementation-surveillance-case-definition-within-eueea (accessed on 20 June 2022).
- Textor, J.; van der Zander, B.; Gilthorpe, M.S.; Liskiewicz, M.; Ellison, G.T. Robust causal inference using directed acyclic graphs: the R package 'dagitty'. Int J Epidemiol 2016, 45, 1887–1894. [Google Scholar] [CrossRef]
- American Association for Clinical Chemistry.Recommendation for reporting SARS-CoV-2 cycle threshold (CT) values. Available online: https://www.aacc.org/-/media/Files/Science-and-Practice/Statements/Recommendationsreporting-SARSCoV2-CT-values.pdf?la=en&hash=0E62FEDEA43FED8AF44404A9B2177756DDC84394 (accessed on 1 March 2023).
- Quiroz-Ruiz, H.R.; Chimoy-Effio, P.J.; Vértiz-Osores, J.J.; Bazán-Mayra, J.E. Correlación entre el umbral de ciclo de la RPC en tiempo real y la clasificación clínica de la COVID-19. Rev Chilena Infectol 2022, 39, 35–44. [Google Scholar] [CrossRef] [PubMed]
- Bobrovitz, N.; Ware, H.; Ma, X.; Li, Z.; Hosseini, R.; Cao, C.; Selemon, A.; Whelan, M.; Premji, Z.; Issa, H.; et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis 2023, 23, 556–567. [Google Scholar] [CrossRef] [PubMed]
- Gascó-Laborda, J.C.; Gil-Fortuño, M.; Ortiz-Rambla, J.; Meseguer-Ferrer, N.; Pérez-Olaso, Ó.; Lluch-Bacas, L.; Moya-Malo, R.; Moliner-Urdiales, D.; Bellido-Blasco, J.B. COVID-19 outbreak in a properly vaccinated nursing home. Influence of hybrid immunity on viral load, risk of infection and risk of disease progression. Rev Esp Salud Publica 2024, 98, e202405036. [Google Scholar]
- Mauriz, E.; Fernández-Vázquez, J.P.; Díez-Flecha, C.; Reguero-Celada, S.; Fernández-Villa, T.; Fernández-Somoano, A.; Caylà, J.A.; Lozano-García, J.A.; Vázquez-Casares, A.M.; Martín-Sánchez, V. Impact of a COVID-19 outbreak in an elderly care home after primary vaccination. Vaccines (Basel) 2023, 11, 1382. [Google Scholar] [CrossRef] [PubMed]
- Henriques, H.R.; Sousa, D.; Faria, J.; Pinto, J.; Costa, A.; Henriques, M.A.; Durão, M.C. Learning from the covid-19 outbreaks in long-term care facilities: a systematic review. BMC Geriatr 2023, 23, 618. [Google Scholar] [CrossRef] [PubMed]
- Meyers, E.; Deschepper, E.; Duysburgh, E.; De Rop, L.; De Burghgraeve, T.; Van Ngoc, P.; Digregorio, M.; Delogne, S.; Coen, A.; De Clercq, N.; et al. Declining prevalence of SARS-CoV-2 antibodies among vaccinated nursing home residents and staff six months after the primary BNT162b2 vaccination campaign in Belgium: A prospective cohort study. Viruses. 2022, 14, 2361. [Google Scholar] [CrossRef] [PubMed]
- Moyet, J.; Helle, F.; Bourdenet, G.; Joseph, C.; Gubler, B.; Deschasse, G.; Defouilloy, I.; Slovenski, T.; François, C.; Liabeuf, S.; et al. Kinetics of SARS-CoV-2-neutralising antibodies of residents of long-term care facilities. J Nutr Health Aging 2022, 26, 57–63. [Google Scholar] [CrossRef] [PubMed]
- Petersen, J.; Jhala, D. COVID-19 cycle threshold/cycle number testing at a community living center. Fed Pract 2022, 39, 254–260. [Google Scholar] [CrossRef] [PubMed]
- Lennon, N.J.; Bhattacharyya, R.P.; Mina, M.J.; Rehm, H.L.; Hung, D.T.; Smole, S.; Woolley, A.; Lander, E.S.; Gabriel, S.B. Cross-Sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities. J Infect Dis 2021, 224, 1658–1663. [Google Scholar] [CrossRef]
- Paap, K.C.; van Loon, A.M.; van Rijs, S.M.; Helmich, E.; Buurman, B.M.; Smalbrugge, M.; Hertogh, C.M.P.M. Symptom- and prevention-based testing of COVID-19 in nursing home residents: A retrospective cohort study. Gerontol Geriatr Med 2021, 7, 23337214211055338. [Google Scholar] [CrossRef] [PubMed]
- Wilson, W.W.; Hatfield, K.M.; Tressler, S.; Bicking Kinsey, C.; Parra, G.; Zell, R.; Denson, A.; Williams, C.; Spicer, K.B.; et al. Characteristics of nursing home residents and healthcare personnel with repeated severe acute respiratory coronavirus virus 2 (SARS-CoV-2) tests positive ≥90 days after initial infection: Four US jurisdictions, July 2020-March 2021. Infect Control Hosp Epidemiol 2023, 44, 809–812. [Google Scholar] [CrossRef] [PubMed]
- Shrotri, M.; Krutikov, M.; Palmer, T.; Giddings, R.; Azmi, B.; Subbarao, S.; Fuller, C.; Irwin-Singer, A.; Davies, D.; Tut, G.; et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): A prospective cohort study. Lancet Infect Dis 2021, 21, 1529–1538. [Google Scholar] [CrossRef] [PubMed]
- Johnson, B.N.; Cooper, L.; Beck, J.J.; Finnicum, C.T.; Davis, C.M.; Van Asselt, A.J.; Kallsen, N.; Silvernail, C.; Viet, S.; Long, K.; et al. More than results: the clinical and research relationship in the evolving detection and surveillance of SARS-CoV-2. S D Med 2023, 76, 248–256. [Google Scholar] [PubMed]
- Shoaib, N.; Iqbal, A.; Shah, F.A.; Zainab, W.; Qasim, M.; Zerqoon, N.; Naseem, M.O.; Munir, R.; Zaidi, N. Population-level median cycle threshold (Ct) values for asymptomatic COVID-19 cases can predict the trajectory of future cases. PLoS One 2023, 18, e0281899. [Google Scholar] [CrossRef] [PubMed]
- Dehesh, P.; Baradaran, H.R.; Eshrati, B.; Motevalian, S.A.; Salehi, M.; Donyavi, T. The relationship between population-level SARS-CoV-2 cycle threshold values and trend of COVID-19 infection: Longitudinal study. JMIR Public Health Surveill 2022, 8, e36424. [Google Scholar] [CrossRef]
- Boogaerts, H.L.F.; Smits, P.; Hans, G.; Bouly, L.; Coeck, E.; Vandamme, S.; Jansens, H.; Goossens, H.; Matheeussen, V. Laboratory analysis of two Delta SARS-CoV-2 variant outbreaks in the Port of Antwerp. Acta Clin Belg 2022, 77, 925–932. [Google Scholar] [CrossRef] [PubMed]
- Nyaruaba, R.; Mwaliko, C.; Dobnik, D.; Neužil, P.; Amoth, P.; Mwau, M.; Yu, J.; Yang, H.; Wei, H. Digital PCR Applications in the SARS-CoV-2/COVID-19 era: A roadmap for future outbreaks. Clin Microbiol Rev 2022, 35, e0016821. [Google Scholar] [CrossRef]
- Miranda, R.L.; Guterres, A.; de Azeredo Lima, C.H.; Filho, P.N.; Gadelha, M.R. Misinterpretation of viral load in COVID-19 clinical outcomes. Virus Res 2021, 296, 198340. [Google Scholar] [CrossRef]
- Han, M.S.; Byun, J.H.; Cho, Y.; Rim, J.H. RT-PCR for SARS-CoV-2: quantitative versus qualitative. Lancet Infect Dis 2021, 21, 165. [Google Scholar] [CrossRef] [PubMed]
- Infectious Disease Society of America and Association for Molecular Pathology joint statement on the use of SARS-CoV-2 PCR cycle threshold (Ct) values for clinical decision-making. Available online: https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-amp-statement.pdf (accessed on 1 March 2024).
- Michaelis, S.; Schneider, C.; Schnedl, W.J.; Baranyi, A.; Enko, D. Comparison of cycle-threshold-values between two commercial SARS-CoV-2 PCR assays. EXCLI J 2023, 22, 397–399. [Google Scholar] [PubMed]
- Dahdouh, E.; Lázaro-Perona, F.; Romero-Gómez, M.P.; Mingorance, J.; García-Rodriguez, J. Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load. J Infect 2021, 82, 414–451. [Google Scholar] [CrossRef] [PubMed]
- Ingberg, E.; Ahlstrand, E.; Cajander, P.; Löf, E.; Sundqvist, M.; Wegener, M.; Lidén, M.; Cajander, S. RT-PCR cycle threshold value in combination with visual scoring of chest computed tomography at hospital admission predicts outcome in COVID-19. Infect Dis (Lond) 2022, 54, 431–440. [Google Scholar] [CrossRef]
- Markewitz, R.; Dargvainiene, J.; Junker, R.; Wandinger, K.P. Cycle threshold of SARS-CoV-2 RT-PCR as a driver of retesting. Sci Rep 2024, 14, 2423. [Google Scholar] [CrossRef] [PubMed]
- Buchta, C.; Görzer, I.; Chiba, P.; Camp, J.V.; Holzmann, H.; Puchhammer-Stöckl, E.; Mayerhofer, M.; Müller, M.M.; Aberle, S.W. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR. Clin Chem Lab Med 2020, 59, 987–994. [Google Scholar] [CrossRef] [PubMed]

| Nursing homes | |||||
| Variables | Center 1 N (%) |
Center 2 N(%) |
Center 3 N(%) |
Center 4 N (%) |
Total N (%) |
| Date of reporting (months/year) | August 2021 | March 2022 | January 2022 | February 2022 | |
| COVID-19 Variant outbreak | Delta B.1.617.2 | Omicrom | Omicrom | Omicrom | |
| Total residents | 125 | 130 | 111 | 106 | 472 |
| Age (years) mean SD | 84.4±8.3 | 82.0±11.0 | 83.8±8.9 | 82.4±10.8 | 83.1±9.8 |
| Female | 90 (72) | 92(70.8) | 74(66.7) | 62 (58.5) | 318(67.4) |
| Male | 35 (28) | 38(29.2) | 37(33.3) | 44 (41.5) | 154(32.6) |
| Elapsed time from former SARS-COV-2 outbreak (days) | 339.9 | 433.1 | 350.5 | 634.9 | 391.81 |
| SARS-CoV-2 Vaccine | 122 (97.6) | 130 (100) | 111(100) | 104 (98.1) | 467(98.9) |
| Elapsed time from last vaccine doses mean SD (days) | 177±28.4 | 154 ±73.6 | 108±36.2 | 154±22.2 | 157±50.1 |
| Total SARS-CoV-2 infections | 57 (45.6) | 125 (96.2) | 94(84.7) | 67(63.2) | 343(72.7) |
| Incidence attack rate (%)2 | 45.6% | 96.2% | 84.7% | 63.2% | 72.7% |
| New SARS-CoV-2 infections | 50 (40) | 63 (48.5) | 93 (83.8) | 43(40.6) | 249(52.8) |
| SARS-CoV-2 reinfections | 7 (5.6) | 62 (47.7) | 1(0.90) | 24(22,6) | 94 (19.9) |
| Reinfections attack rate (%)2 | 5.6% | 47.7% | 0.90% | 22.6% | 19.9% |
| Mortality rate | 6 (4.8%) | 7 (5.4%) | 6(5.4%) | 0 | 19 (4.0%) |
| Fatality rate | 10.6% | 17.9% | 1.1% | 0 | 5.5% |
| Nursing homes | |||||
| Variables | Centre 1 N (%) |
Centre 2 N (%) |
Centre 3 N (%) |
Centre 4 N (%) |
Total N (%) |
| Residents with PCR-Ct | 38 | 90 | 92 | 32 | 252 |
| Age | 85.0±6.7 | 81.9±11.6 | 84.7±8.4 | 80.4±12.0 | 83.2±10.0 |
| Female | 32(84.2) | 66(73.3) | 66(71.7) | 20(62.5) | 184(73.0) |
| Male | 6 (15.8) | 24(26.7) | 26(28.3) | 12(37.5) | 68(27.0) |
| Fist infection with PCR-Ct | 33( 86.8) | 42(46.7) | 91(98.9) | 19(59.4) | 185(73.4) |
| Reinfections with PCR-Ct | 5 (13.2) | 48 (53.3) | 1(1.1) | 13(40.6) | 67(26.6) |
| Reinfections without PCR-Ct | 2 (5.3) | 14(15.6) | 0 | 11(34.4) | 27(10.7) |
| Cycle threshold (median-range) | 23.3(17-38) | 33.5(11-39) | 27 (17-38) | 29(15-37) | 29(11-39) |
| Cycle threshold mean ± SD | 25.2±6.2 | 30.9±7.0 | 27.2±5.7 | 28.4±6.6 | 28.4±6.7 |
| Ct SARS-CoV-2 reinfections | 36.4±3.0 | 32.5±4.9 | 26.0 | 28.1±5.7 | 31.9±5.4 |
| Ct first SARS-CoV-2 infections | 23.5±4.5 | 29.0±8.5 | 27.3±5.7 | 28.6±7.3 | 27.1±6.6 |
| p-values | 0.000 | 0.016 | 0.876 | 0.820 | 0.000 |
| Cycle thresholds | ||||||||
| Ct ≥30 n=123(%) |
Ct<30 n=129 (%) |
Total | cRR | 95% CI | aRR | 95% CI | p-value | |
| Age1 mean±SD | 82.9±10.1 | 83.5±10.0 | - | 1.00 | 0.98-1.01 | 0.991 | 0.98-1.01 | 0.675 |
| Male2 | 32(47.1) | 36(52.9) | 68 | 0.95 | 0.64-1.42 | 0.922 | 0.59-1.42 | 0.703 |
| Female | 91(49.5) | 93(50.5) | 184 | 1.00 | 1.00 | |||
| Elapse time from former SARS-CoV-2 outbreak 3 (days) mean±SD | 427.9±86.8 | 401.7±97.3 | - | 1.00 | 0.99-1.00 | 1.003 | 1.00-1.01 | 0.031 |
| Nursing homes4 | ||||||||
| Centre 1 | ||||||||
| SARS-CoV-2 Reinfections | 5(100) | 0(0) | 5 | 6.60 | 1.91-22.80 | 6.70 | 1.80-25.0 | 0.005 |
| First SARS-CoV-2 Infections | 5(15.2) | 28(84.8) | 33 | 1.00 | ||||
| Centre 2 | ||||||||
| SARS-CoV-2 Reinfections | 39(81.3) | 9(18.8) | 48 | 1.31 | 0.80-2.16 | 1.31 | 0.80-2.15 | 0.287 |
| First SARS-CoV-2 Infections | 26(61.9) | 16(38.1) | 42 | 1.00 | ||||
| Centre 3 | ||||||||
| SARS-CoV-2 Reinfections | 0 (0) | 1(100) | 1 | 1.935 | 0.0-10.76 | 2.186 | 0.0-14.25 | 1.000 |
| First SARS-CoV-2 Infections | 33(34.1) | 58(63.7) | 91 | 1.00 | ||||
| Centre 4 | ||||||||
| SARS-CoV-2 Reinfections | 5 (38.5) | 8(61.5) | 13 | 0.73 | 0.20-2.34 | 0.70 | 0.24-2.05 | 0.513 |
| First SARS-CoV-2 Infections | 10(52.6) | 9(47.4) | 19 | 1.00 | ||||
| Total nursing homes7 | ||||||||
| SARS-CoV-2 Reinfections | 49(73.1) | 18 (26.9) | 67 | 1.83 | 1.27-2.62 | 1.66 | 1.10-2.51 | 0.015 |
| First SARS-CoV-2 Infections | 74 (40.0) | 111 (60.0) | 185 | 1.00 | 1.00 | |||
| Reinfections | |||||||
| Yes n=67 | No n=185 | cOR | 95% CI | aOR | 95% | p-value | |
| Cycle threshold1 | N (%) | N (%) | |||||
| Minor (<18.83) | 1 (1.5) | 19 (10.3) | 1.00 | 1.00 | |||
| Medium (≥18.83-30.10) | 17 (25.4) | 99 (53.5) | 3.26 | 0.41-26.00 | 5.98 | 0.73-49.12 | 0.096 |
| High (>30.10) | 49 (73.1) | 67 (36.2) | 13.90 | 1.80-107.33 | 17.63 | 2.22-139.86 | 0.007 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
